ijms-logo

Journal Browser

Journal Browser

Molecular Mechanisms and Treatment of Retinal Diseases

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: 30 November 2025 | Viewed by 69

Special Issue Editors

Optometry/Ophthalmic Optics, Gangdong University, Chungcheongbuk-do 27600, Republic of Korea
Interests: retinal ischemic diseases; anti-aging; anti-Inflammation; neuroprotection; retinal metabolism; nutritional supplements; bioinformatics; vitamins; retinal dysfunction; fibrosis; peroxisome proliferator-activated receptor; hypoxia-inducible factor; nicotinamide adenine dinucleotide; drug delivery; experimental model development; pathology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The retina in the eye is essential for vision and is highly vulnerable to a range of pathological insults. Retinal degeneration due to aging, inflammation, and vascular damage remains a major cause of irreversible vision loss worldwide. In recent years, significant attention has been directed toward the role of metabolic regulation in maintaining retinal health, particularly in the context of high myopia, age-related macular degeneration, and glaucoma. Clinical and experimental studies suggest that targeted nutrients may exert protective effects by reducing oxidative stress, modulating inflammation, and preserving retinal integrity. Furthermore, innovative therapies such as cell-based treatments and advanced drug delivery systems, including eye drops capable of crossing ocular barriers, have emerged as promising strategies to restore or preserve vision. Light therapy has also gained interest as a non-invasive modality to modulate retinal physiology and potentially slow down degenerative progression.

This Special Issue will focus on recent advances across multiple fronts—including nutritional interventions, optometric management, regenerative therapies, drug delivery innovations, and digital health applications to address retinal degeneration, ischemia, and inflammatory retinal disorders in various eye diseases. By bringing together cutting-edge research and clinical insights, this collection can inspire new therapeutic strategies that can protect vision and enhance quality of life worldwide.

Dr. Deokho Lee
Dr. Livio Vitiello
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nutritional supplementations
  • high myopia
  • optometry
  • cell therapy
  • drug delivery
  • age-related macular degeneration
  • glaucoma
  • retinal degeneration
  • choroidal thinning
  • scleral remodeling
  • light therapy
  • digital healthcare
  • prematurity of retionopathy
  • carotid artery occlusion
  • retinal ischemia
  • inflammation
  • eye drop

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop